ArticleFrontiers in oncology2024

A good response to anti-PD-1 monoclonal antibody plus SBRT in a patient with PD-L1-negative recurrent advanced esophageal cancer: a long-term follow-up case report of a possible abscopal effect.

Tao Hai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.